Advertisement
Advertisement
U.S. markets open in 8 hours 43 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Revive Therapeutics Ltd. (RVVTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3411+0.0068 (+2.02%)
At close: 03:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3343
Open0.3320
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3250 - 0.3474
52 Week Range0.1200 - 0.5100
Volume312,270
Avg. Volume606,541
Market Cap109.37M
Beta (5Y Monthly)-0.42
PE Ratio (TTM)N/A
EPS (TTM)-0.0570
Earnings DateMay 30, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for RVVTF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • REVIVE THERAPEUTICS LTD
    FLGT: Raising target price to $53.00FULGENT GENETICS INC has an Investment Rating of HOLD; a target price of $53.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
Advertisement
Advertisement